SS Innovations International Files 8-K

Ticker: SSII · Form: 8-K · Filed: Apr 22, 2024 · CIK: 1676163

Sentiment: neutral

Topics: 8-K, corporate-update, financials

TL;DR

SS Innovations International filed an 8-K on 4/22/24. Standard corporate update.

AI Summary

SS Innovations International, Inc. (formerly AVRA Medical Robotics, Inc.) filed an 8-K on April 22, 2024, reporting other events and financial statements. The company, incorporated in Florida with its principal executive offices in Fort Lauderdale, operates in the surgical and medical instruments sector.

Why It Matters

This filing indicates that SS Innovations International, Inc. is providing updates on its corporate activities and financial status to the SEC.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for corporate updates and does not appear to contain significant new risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of SS Innovations International, Inc.?

SS Innovations International, Inc. operates in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry, SIC code 3841.

When was SS Innovations International, Inc. previously known by another name?

The company was formerly known as AVRA Medical Robotics, Inc., with a date of name change on June 1, 2016.

Where are the principal executive offices of SS Innovations International, Inc. located?

The principal executive offices are located at 1600 SE 15th Street, #512, Fort Lauderdale, Florida 33316.

What is the fiscal year end for SS Innovations International, Inc.?

The fiscal year end for SS Innovations International, Inc. is December 31.

What items are being reported in this 8-K filing?

This 8-K filing reports 'Other Events' and 'Financial Statements and Exhibits'.

Filing Stats: 454 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-04-22 08:30:13

Filing Documents

01 Other Events

Item 8.01 Other Events. On April 22, 2024, we issued a press release providing Company updates for the first quarter of 2024. A copy of the press release is included as Exhibit 99.1 to this Report.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated April 22, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 22, 2024 SS INNOVATIONS INTERNATIONAL, INC. By: /s/ Sudhir Srivastava Sudhir Srivastava, M.D. Chairman and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing